Overview
Binds to GnRH receptors with high affinity, causing initial gonadotropin release followed by receptor desensitization and downregulation.
Proposed mechanism
Leuprolide is a potent GnRH agonist that initially stimulates then downregulates pituitary GnRH receptors, suppressing LH/FSH and sex hormone production.
What the evidence supports
Human data exists but the trials are small, short-term, or not yet replicated.
Graded Human-limited
Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Leuprolide for prostate cancer
· DOI:10.1056/NEJM199505043321812 · 1995
- [2]
GnRH agonists review
· DOI:10.1016/j.eururo.2006.02.015 · 2006
- [3]
Leuprolide for prostate cancer (1995)
· · 0
- [4]
GnRH agonists review (2006)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.